SEC Form 4/A · accession 0001209191-17-066067
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Andrea van Elsas
Officer — Chief Scientific Officer
Period of report
Sep 12, 2017
Accepted (ET)
Dec 15, 2017 · 7:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 12, 2017 | A | 27,975 | $0.00 | A | 207,503 | D | |
| Common Stock | Sep 13, 2017 | S | 4,922 | $10.9858 | D | 202,581 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is being filed to correct the ministerial error in the number of shares granted in restricted stock units to the Reporting Person.
- F2Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2017.
- F3The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.